60
Participants
Start Date
March 31, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
September 30, 2013
PMV via Puffhaler® device
The vaccine will be administered via a Puffhaler® device. A single dose of 10 mg of PMV (dry powder measles vaccine) will be used.
PMV via SoloventTM device
The vaccine will be administered via SoloventTM device. A single dose of 10 mg of PMV (dry powder measles vaccine) will be used.
Licensed Subcutaneous Measles Vaccine
This is a licensed formulation containing the live attenuated Edmonston Zagreb virus. A single dose of 0.5 ml will be given subcutaneously.
Department of Pediatrics, Padmashree Dr. D. Y. Patil Medical College, Pune
University of Colorado, Boulder
OTHER
Centers for Disease Control and Prevention
FED
Serum Institute of India Pvt. Ltd.
INDUSTRY